Varunadi Kwath: Herbal Decoction for Kidney Stones and Urinary Pain

Varunadi Kwath for Kidney Stones: Clinical Application and Protocol

A 44-year-old patient arrived with a 6 mm calcium-oxalate stone in the right distal ureter near the ureterovesical junction, confirmed on CT urogram. His urologist had prescribed an alpha-blocker such as tamsulosin and advised a limited period of observation before considering ureteroscopy. This is the type of passable-stone situation where varunadi kwath kidney stones treatment may be considered as a supervised Ayurvedic adjunct: not to replace imaging, pain control, medical expulsive therapy, or urological decision-making, but to support urinary flow, mutravaha srotas, and recurrence-prevention measures.

Ayurvedic and Urological Context

In Ayurveda, urinary stones are understood under mutrashmari, a stone-forming disorder of the urinary system. The therapeutic logic is to support mutrala action, reduce urinary obstruction and burning, assist the passage of small stones when passage is medically appropriate, and correct the diet-and-fluid conditions that allow crystals to form. In current urology guidance, distal ureteral stones in the 5–10 mm range may be managed with observation and alpha-blocker medical expulsive therapy when there is no infection, kidney-threatening obstruction, uncontrolled pain, or other urgent indication. Varunadi kwath belongs only in that supervised, non-emergency window.

Which Varunadi Kwath?

The name “Varunadi” can refer to different preparations, so the label matters. The Kerala Varanadi Kashayam of Varunadi gana is a separate 16-herb formula used mainly in kapha-meda contexts and should not automatically be treated as the stone-focused kwath. For urinary-stone protocols, the more relevant Varuna/Varunadi-style kwath churna centers on varuna stem bark with pashanabheda, gokshura, and sunthi. Some ready-made Varunadi Kadha liquids also list dhataki flower and jaggery, so commercial dosage and composition should be followed exactly as printed or as prescribed by the practitioner.

Formulation Components and Their Ayurvedic Rationale

Varuna (Crataeva nurvala Buch.-Ham.) stem bark is the anchor herb. The Ayurvedic Pharmacopoeia identifies Varuna as the dried stem bark of Crataeva nurvala, and the herb has a long urinary-use tradition. Its contemporary rationale in calcium-oxalate stone care includes actions observed around oxalate metabolism, urinary stone-forming factors, and crystal deposition in experimental calcium-oxalate models.

Pashanabheda is the stone-directed companion herb. The Ayurvedic Pharmacopoeia identifies it as the rhizome of Bergenia ciliata, with Bergenia ligulata listed as a synonym. Its Sanskrit synonyms such as ashmabhedaka and shilabheda preserve the traditional “stone-splitting” sense. Its practical role in this formula is to support the ashmari indication, especially where calcium-oxalate crystallization and aggregation are central concerns.

Gokshura (Tribulus terrestris) is used for mutrala support and urinary comfort. In a stone-passage protocol, its role is not to “melt” a stone instantly but to support urine flow, reduce the tendency toward urinary stagnation, and complement the stone-directed herbs.

Sunthi (Zingiber officinale) is included in many Varuna Kwatha-style combinations for dipana-pachana support. Bark and rhizome decoctions can be heavy, bitter, and drying; sunthi helps the formula sit better in digestion and is especially useful when the patient has sluggish appetite or heaviness. Patients with marked acidity, gastritis, burning, or high pitta symptoms should use the formula only after practitioner assessment.

Preparation Protocol

Use authenticated coarse kwath churna, not fine powder of uncertain identity. A classical decoction method is to add 16 parts water to 1 part coarse herb mixture and simmer on mild heat until one-eighth remains; for example, 20 g coarse mixture with 320 ml water reduced to about 40 ml. Strain warm and prepare fresh daily. If using a ready-made Varunadi Kadha liquid, follow the product label or practitioner’s prescription rather than converting it into the raw-herb decoction dose.

For a fresh decoction, a common supervised adult range is 40–50 ml once or twice daily, preferably after food when the stomach is sensitive. Take it with additional plain water unless a physician has restricted fluids. During kidney-stone care, hydration should be individualized, but many adults are advised to drink enough fluid to keep urine pale and to produce roughly 2–2.5 liters of urine daily. Do not force fluids in chronic kidney disease, heart failure, severe swelling, hyponatremia risk, or any condition where a physician has given a fluid limit.

Dosage by Indication

The following table gives a practical, practitioner-supervised framework. It is not a self-treatment schedule, and it should be adjusted for constitution, digestion, kidney function, concurrent medicines, stone size, stone position, and imaging findings.

Dietary Adjuncts for Stone Management

For calcium-oxalate stones, the diet should reduce excess oxalate burden without removing calcium from meals. High-oxalate foods such as spinach, rhubarb, nuts and nut products, peanuts, wheat bran, and large amounts of beetroot should be limited when calcium-oxalate stones or high urinary oxalate are present. Adequate food-based calcium with meals is useful because calcium can bind oxalate in the digestive tract before oxalate reaches the urine. Sodium reduction is equally important, because higher sodium intake increases urinary calcium loss. Excess animal protein can raise stone risk in susceptible patients, so portions of meat, eggs, fish, and shellfish should be individualized and often reduced.

For uric-acid stones, the main target is urine acidity and purine load. Reducing red meat, organ meats, shellfish, and excessive animal protein is more relevant here, while urine alkalinization should be guided by a physician. Lemon water can be a gentle dietary support for citrate intake, but it is not the same as prescribed potassium citrate and should not be used as a substitute when medication is indicated.

For recurrent stones, a 24-hour urine stone profile is one of the most useful tools because it can identify low urine volume, high calcium, high oxalate, high uric acid, low citrate, high sodium, and other correctable drivers. The mutravaha srotas framework gives the Ayurvedic channel context, but long-term prevention should combine Ayurvedic assessment with stone analysis, urine testing, diet review, and follow-up imaging when advised.

When Not to Use as a Home Protocol

Do not self-treat kidney stones with Varunadi Kwath if there is fever, chills, repeated vomiting, uncontrolled pain, inability to pass urine, known severe hydronephrosis, rising creatinine, a single functioning kidney, pregnancy, kidney transplant, advanced kidney disease, or a stone that the urologist has said is unlikely to pass. Stones larger than the conservative-management range, infected stones, and obstructing stones can become emergencies. Herbal treatment should never delay urgent urological care.

Clinical Bottom Line

Varunadi Kwath is best understood as a supervised Ayurvedic adjunct for selected, passable urinary stones and recurrent stone prevention, especially when the formula is the Varuna-Pashanabheda-Gokshura-Sunthi style preparation rather than a different Varunadi formula. Its value is highest when combined with adequate hydration, stone-type-specific diet, urine testing, imaging follow-up, and conventional treatment when indicated. This article is educational and does not diagnose or treat disease; consult a qualified Ayurvedic practitioner and a physician or urologist before starting herbs, supplements, detoxes, or therapeutic protocols, especially if pregnant, managing kidney disease, or taking medication.

References

1. Uroweb (uroweb.org)
2. Auanet (auanet.org)
3. Management of Mutrashmari (urolithiasis) with Palasha Kshara and Ashmarihara Kwatha: An open-labelled placebo-controlled clinical trial (2022), PubMed Central
4. Evaluation of anti-inflammatory effect of Varanadi Kashayam (decoction) in THP-1-derived macrophages (2018), PubMed Central
5. Ijpsr (ijpsr.com)
6. Baidyanath (baidyanath.co)
7. Ayurvedarasashala (ayurvedarasashala.com)
8. Ia800501 (ia800501.us.archive.org)
9. Effect of Crataeva nurvala in experimental urolithiasis (1990), PubMed
10. Effect of lupeol, a pentacyclic triterpene, on urinary enzymes in hyperoxaluric rats (1995), PubMed
11. Ayurvedic Pharmacopoeia of India
12. Antiurolithic effect of Bergenia ligulata rhizome: an explanation of the underlying mechanisms (2009), PubMed
13. A comparative diuretic evaluation of fruit and root of Gokshura (Tribulus terrestris Linn.) in albino rats (2021), PubMed Central
14. Delving into the Antiurolithiatic Potential of Tribulus terrestris Extract Through -In Vivo Efficacy and Preclinical Safety Investigations in Wistar Rats (2019), PubMed Central
15. Jaims (jaims.in)
16. NIDDK
17. Kidney (kidney.org)
18. Kidney (kidney.org)